ZOETIS INC (ZTS) Fundamental Analysis & Valuation
NYSE:ZTS • US98978V1035
Current stock price
116.69 USD
+0.76 (+0.66%)
Last:
This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZTS Profitability Analysis
1.1 Basic Checks
- In the past year ZTS was profitable.
- ZTS had a positive operating cash flow in the past year.
- Each year in the past 5 years ZTS has been profitable.
- ZTS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ZTS has a better Return On Assets (17.28%) than 95.85% of its industry peers.
- ZTS has a better Return On Equity (80.25%) than 99.48% of its industry peers.
- With an excellent Return On Invested Capital value of 21.95%, ZTS belongs to the best of the industry, outperforming 97.41% of the companies in the same industry.
- ZTS had an Average Return On Invested Capital over the past 3 years of 22.23%. This is significantly above the industry average of 13.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROIC | 21.95% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1.3 Margins
- ZTS has a Profit Margin of 28.23%. This is amongst the best in the industry. ZTS outperforms 93.78% of its industry peers.
- In the last couple of years the Profit Margin of ZTS has grown nicely.
- The Operating Margin of ZTS (38.54%) is better than 97.41% of its industry peers.
- In the last couple of years the Operating Margin of ZTS has grown nicely.
- Looking at the Gross Margin, with a value of 71.89%, ZTS is in the better half of the industry, outperforming 79.79% of the companies in the same industry.
- ZTS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% |
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
2. ZTS Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ZTS is creating value.
- ZTS has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for ZTS has been reduced compared to 5 years ago.
- ZTS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.41 indicates that ZTS is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.41, ZTS is in the better half of the industry, outperforming 78.76% of the companies in the same industry.
- The Debt to FCF ratio of ZTS is 3.96, which is a good value as it means it would take ZTS, 3.96 years of fcf income to pay off all of its debts.
- ZTS has a better Debt to FCF ratio (3.96) than 86.53% of its industry peers.
- A Debt/Equity ratio of 2.71 is on the high side and indicates that ZTS has dependencies on debt financing.
- ZTS has a Debt to Equity ratio of 2.71. This is in the lower half of the industry: ZTS underperforms 79.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Altman-Z | 5.41 |
ROIC/WACC2.42
WACC9.09%
2.3 Liquidity
- A Current Ratio of 3.03 indicates that ZTS has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 3.03, ZTS is in line with its industry, outperforming 53.89% of the companies in the same industry.
- A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
- ZTS has a Quick ratio of 1.94. This is comparable to the rest of the industry: ZTS outperforms 46.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 |
3. ZTS Growth Analysis
3.1 Past
- ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
- Measured over the past years, ZTS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.77% on average per year.
- The Revenue has been growing slightly by 2.28% in the past year.
- Measured over the past years, ZTS shows a small growth in Revenue. The Revenue has been growing by 7.24% on average per year.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
3.2 Future
- The Earnings Per Share is expected to grow by 7.80% on average over the next years.
- Based on estimates for the next years, ZTS will show a small growth in Revenue. The Revenue will grow by 5.30% on average per year.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.9%
Revenue Next 2Y4.87%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ZTS Valuation Analysis
4.1 Price/Earnings Ratio
- ZTS is valuated rather expensively with a Price/Earnings ratio of 18.18.
- Based on the Price/Earnings ratio, ZTS is valued cheaper than 84.46% of the companies in the same industry.
- ZTS is valuated rather cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
- ZTS is valuated correctly with a Price/Forward Earnings ratio of 16.49.
- Based on the Price/Forward Earnings ratio, ZTS is valued cheaper than 81.35% of the companies in the same industry.
- ZTS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 16.49 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ZTS is valued cheaper than 83.42% of the companies in the same industry.
- 83.94% of the companies in the same industry are more expensive than ZTS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.58 | ||
| EV/EBITDA | 13.46 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ZTS may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)1.69
EPS Next 2Y8.92%
EPS Next 3Y8.7%
5. ZTS Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.64%, ZTS has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.79, ZTS pays a better dividend. On top of this ZTS pays more dividend than 91.19% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, ZTS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- On average, the dividend of ZTS grows each year by 20.56%, which is quite nice.
- ZTS has paid a dividend for at least 10 years, which is a reliable track record.
- ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- ZTS pays out 33.26% of its income as dividend. This is a sustainable payout ratio.
- ZTS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
ZTS Fundamentals: All Metrics, Ratios and Statistics
NYSE:ZTS (3/25/2026, 1:40:40 PM)
116.69
+0.76 (+0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12 2026-02-12/bmo
Earnings (Next)05-04 2026-05-04/bmo
Inst Owners100.79%
Inst Owner Change4.39%
Ins Owners0.07%
Ins Owner Change3.87%
Market Cap49.26B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target155.47 (33.23%)
Short Float %4.12%
Short Ratio3.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-20 2026-04-20 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-2.51%
PT rev (3m)-8.55%
EPS NQ rev (1m)1.01%
EPS NQ rev (3m)2.69%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 16.49 | ||
| P/S | 5.2 | ||
| P/FCF | 21.58 | ||
| P/OCF | 16.96 | ||
| P/B | 14.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.46 |
EPS(TTM)6.42
EY5.5%
EPS(NY)7.08
Fwd EY6.07%
FCF(TTM)5.41
FCFY4.63%
OCF(TTM)6.88
OCFY5.9%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.77
PEG (5Y)1.69
Graham Number33.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROCE | 27.58% | ||
| ROIC | 21.95% | ||
| ROICexc | 26.6% | ||
| ROICexgc | 40.59% | ||
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% | ||
| FCFM | 24.12% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Debt/EBITDA | 2.19 | ||
| Cap/Depr | 127.52% | ||
| Cap/Sales | 6.56% | ||
| Interest Coverage | 13.98 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 85.41% | ||
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 5.41 |
F-Score6
WACC9.09%
ROIC/WACC2.42
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.9%
Revenue Next 2Y4.87%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%
ZOETIS INC / ZTS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?
ChartMill assigns a fundamental rating of 7 / 10 to ZTS.
Can you provide the valuation status for ZOETIS INC?
ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.
How profitable is ZOETIS INC (ZTS) stock?
ZOETIS INC (ZTS) has a profitability rating of 9 / 10.
Can you provide the expected EPS growth for ZTS stock?
The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.25% in the next year.
Is the dividend of ZOETIS INC sustainable?
The dividend rating of ZOETIS INC (ZTS) is 7 / 10 and the dividend payout ratio is 33.26%.